RADIOTHERAPY OF MALIGNANT-MELANOMA OF THE UVEA WITH I-125 SEEDS

被引:0
作者
HEIKKONEN, J
SUMMANEN, P
IMMONEN, I
TOMMILA, P
TOIVOLA, H
FORSS, M
TARKKANEN, A
机构
[1] HELSINKI UNIV, CENT HOSP, DEPT OPHTHALMOL, SF-00290 HELSINKI, FINLAND
[2] HELSINKI UNIV, CENT HOSP, DEPT OBSTET & GYNECOL 1, SF-00290 HELSINKI, FINLAND
[3] HELSINKI UNIV, CENT HOSP, DEPT OBSTET & GYNECOL 2, SF-00290 HELSINKI, FINLAND
关键词
MALIGNANT UVEAL MELANOMA; I-125; I-125-IRRADIATION; EYE PLAQUES; BRACHYTHERAPY; DOSIMETRY; DOSE PLANNING;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Nineteen patients with malignant uveal melanomas were treated with I-125 applicators. There were 10 males and 9 females with a median age of 61 years (range 42-76). The tumour was located in the choroid in 12 eyes and in the choroid and ciliary body in 7 eves. The size of the tumours was 7-18 mm in maximal basal diameter (median 12),5-16 mm in minimal basal diameter (median 10), and 5.5-15 mm in thickness (median 8.5). The volume of the tumours was 123-1890 mm3 (median 540). All tumours were classified as large (T3). For the irradiation, a computer program, which calculates three-dimensional dose distribution of I-125 seeds in gold plaques, was developed. By modifying the seed positions, activity and the orientation, patients can be treated individually. Iodine-125 emits low energy photons, ideal for intraocular tumour therapy and tissue. Extra-ocular tissue located behind the applicator can be completely shielded by a 0.5 mm gold layer. The dose at the apex of the tumour ranged from 30 to 120 Gy (median 93). The treatment time ranged from 44 to 600 h (median 235). Preliminary results are good. After a median follow-up of 6 months, the tumour growth has been arrested in all eyes and in 10 eyes the tumour has decreased in size.
引用
收藏
页码:780 / 785
页数:6
相关论文
共 12 条
[1]   AN INTERACTIVE TREATMENT PLANNING SYSTEM FOR OPHTHALMIC PLAQUE RADIOTHERAPY [J].
ASTRAHAN, MA ;
LUXTON, G ;
JOZSEF, G ;
KAMPP, TD ;
LIGGETT, PE ;
SAPOZINK, MD ;
PETROVICH, Z .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (03) :679-687
[2]  
Hermanek P, 1987, TNM CLASSIFICATION M, P158
[3]   IMPROVED I-125 PLAQUE DESIGN IN THE TREATMENT OF CHOROIDAL MALIGNANT-MELANOMA [J].
HILL, JC ;
SEALY, R ;
SHACKLETON, D ;
STANNARD, C ;
KORRUBEL, J ;
HERING, E ;
LOXTON, C .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1992, 76 (02) :91-94
[4]   COMPUTER-ASSISTED TREATMENT PLANNING FOR I125 OPHTHALMIC PLAQUE RADIOTHERAPY [J].
LING, CC ;
CHEN, GTY ;
BOOTHBY, JW ;
WEAVER, K ;
STUART, A ;
BARNETT, C ;
CHAR, D ;
PHILLIPS, TL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (02) :405-410
[5]   TWO-DIMENSIONAL DOSE DISTRIBUTION OF I125 SEEDS [J].
LING, CC ;
SCHELL, MC ;
YORKE, ED ;
PALOS, BB ;
KUBIATOWICZ, DO .
MEDICAL PHYSICS, 1985, 12 (05) :652-655
[7]   EFFECTIVE ATTENUATION IN WATER OF GAMMA RAYS OF GOLD 198 IRIDIUM 192 CESIUM 137 RADIUM 226 AND COBALT 60 [J].
MEISBERGER, LL ;
KELLER, RJ ;
SHALEK, RJ .
RADIOLOGY, 1968, 90 (05) :953-+
[8]  
PACKER S, 1980, OPHTHALMOLOGY, V87, P582
[9]  
PACKER S, 1984, OPHTHALMOLOGY, V91, P1700
[10]   DOSE DISTRIBUTIONS OF MODEL 6702 I-125 SEEDS IN WATER [J].
SCHELL, MC ;
LING, CC ;
GROMADZKI, ZC ;
WORKING, KR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (05) :795-799